Preclinical

Industry pros thankful, hopeful on Clinical Trials Day 2022

19-May-2022 By Jenni Spinner

Experts and organizations are honoring the occasion (designed to celebrate research accomplishments and achievements) with insights, education, and more.

Machine learning can unlock potential of EEG data: Beacon Biosignals

18-May-2022 By Jenni Spinner

A leader from the neurobiomarker platform provider tells how use of ML and other advanced analytical tools can help make better use of complex information.

Artificial intelligence stands to transform precision medicine: AiCure

18-May-2022 By Jenni Spinner

An expert from the AI-focused technology company shares insights as to how it can be harnessed to better interpret, and even predict, patient behavior.

University of California at Irvine launches Institute for Precision Health

18-May-2022 By Jenni Spinner

The institute will combine the university’s AI, ML, health science, engineering, genomics, and data capabilities to tackle health strategy and inequity.

Lilly deploys AI-powered tech to expedite drug approval process

18-May-2022 By Jenni Spinner

The pharmaceutical company is partnering with Yseop to install the software company’s Augmented Analyst, designed to elevate and accelerate data analysis.

Breast cancer trial patient participants younger than ever: Phesi

16-May-2022 By Jenni Spinner

The company’s analysis of 2.5m patients worldwide suggest a growing proportion of younger patients, with implications for future study design and deployment.

Charles River, Valo join on AI-enabled drug discovery offering

10-May-2022 By Nick Taylor

The CRO has paired with the drug discovery technology firm on Logica, an artificial intelligence tool designed to accelerate development of new treatments.

Takeda joins with Xavier University to increase equity in healthcare

09-May-2022 By Jenni Spinner

The pharmaceutical firm and university have launched T-REX, a multi-year partnership focused on increasing health outcomes for underrepresented populations.

Illumina secures drug discovery tie-ups with Janssen, Deerfield

09-May-2022 By Jane Byrne

Illumina has recently announced a 10-year-long strategic collaboration with Janssen Biotech, and a five-year partnership with Deerfield Management.

People on the Move: May 2022

05-May-2022 By Jenni Spinner

This month’s news on partnerships, appointments, expansions, and investment includes Javara, ACG, Phastar, Elligo Health Research, and other notable companies.

AI use in life science not yet at full potential: IBM Research

03-May-2022 By Jenni Spinner

Leaders from the R&D tech company weigh in on how use of artificial intelligence has grown, ongoing challenges to effective adoption, and what lies ahead.

Pistoia Alliance calls for more pharma-patient collaboration in early R&D

02-May-2022 By Jenni Spinner

A leader from the life-science organization discusses how collaboration could lead to a broad range of benefits for everyone along the drug discovery pipeline

Vocal biomarker use can elevate patient monitoring: Sonde Health

28-Apr-2022 By Jenni Spinner

A leader from the health tech company explains how voice-based technologies could transform monitoring of patients with dementia, Alzheimer’s, and other conditions.

Sionna raises $111m to take molecules against CF target into the clinic

28-Apr-2022 By Nick Taylor

Newly launched life sciences company Sionna Therapeutics has secured funding to fuel discovery and development of drug candidates to treat cystic fibrosis.

CMC lands funding to develop treatment for nerve agent poisoning

19-Apr-2022 By Jenni Spinner

The CDMO has been awarded funding from the US government to work on treatments for sarin and other substances used frequently employed in chemical attacks.

RWE can boost trial acceleration, cost efficiency, and inclusivity

13-Apr-2022 By Jenni Spinner

An expert from trial tech specialist Komodo Health talks about how real-world evidence use could elevate study design, conserve costs, and improve recruitment.

UK-based collaborators to create world’s largest cancer database

12-Apr-2022 By Jenni Spinner

The partnership among three research and data specialists is aimed at creating a global database to support faster development of novel cancer treatments.

Former Johnson & Johnson, Bristol Myers Squibb executive to lead COTA

12-Apr-2022 By Jenni Spinner

Miruna Sasu has been named president and CEO of the company, which uses RWD and analytics in advancing oncology drug development and clinical trial diversity.

Winterlight Labs pitches in on decentralizing Alzheimer’s research

11-Apr-2022 By Jenni Spinner

The biomarker developer is partnering with Alzheimer Center Amsterdam on decentralized assessment of patient cognition and function in preclinical research.

People on the Move: April 2022

11-Apr-2022 By Jenni Spinner

This month’s news includes hiring, promotions, expansions, and acquisitions at H Clinical, Charles River, DHL Supply Chain, X-Chem, and other key companies.

Cancer researcher nabbed for falsifying data in PHS-funded grants

07-Apr-2022 By Jenni Spinner

The US Department of Health and Human Service’s Office of Research Integrity has uncovered evidence that Toni Brand committed fraud in a number of reports.

Innovative Purdue research leads to FDA-approved prostate cancer treatment

31-Mar-2022 By Jenni Spinner

A renowned university researcher explains the path that laid the foundation and what the novel diagnostic and treatment means for prostate cancer patients.

Roche, BMS to partner on personalized solutions for cancer patients

28-Mar-2022 By Jenni Spinner

The companies plan to work on developing personalized care solutions via digital pathology to come up with treatment options for patients with solid tumors.

The right tech can fill gap between lab scientist and data: ACD/Labs

16-Mar-2022 By Jenni Spinner

An expert from the R&D tech provider discusses how automation, integration, and other tools can help with effective access and analysis of lab information.

AbbVie, Gedeon Richter to partner on developing neuropsychiatric drugs

15-Mar-2022 By Jenni Spinner

The US- and Hungary-based pharma firms will work on research, development, and commercialization of dopamine receptor modulators for potential treatments.

Pharma leaders should step up on artificial intelligence: ConcertAI

14-Mar-2022 By Jenni Spinner

An executive from the AI specialist discusses how recent advances have provided opportunities for industry professionals to champion new ways of thinking.

Enveric taps University of Calgary to study psychedelic therapy in cancer-related distress

14-Mar-2022 By Nick Taylor

The pharma company and academic institution will explore the viability of a psychedelic treatment to help patients suffering from cancer-related distress.

App taps into patient data to explore human side of cancer

10-Mar-2022 By Jenni Spinner

Patient-centric company Belong.life has developed an app designed to inform cancer research by offering a holistic view of the lives of people with cancer.

Sanofi US forms digital therapeutics partnership with DarioHealth

08-Mar-2022 By Jenni Spinner

The pharmaceutical company and the digital therapeutics specialist are joining forces to help accelerate the expansion of various digital health solutions.

Pfizer, CytoReason extend AI pact after immune system success

08-Mar-2022 By Nick Taylor

The drug company has renewed its arrangement with the artificial intelligence specialist, centered on using AI to improve understanding of the immune system.

Boehringer Ingelheim, Lifebit team up to build data platform

07-Mar-2022 By Jenni Spinner

The pharma firm has allied with the biotech to create a scalable data, analytics, and infrastructure platform to generate insights from healthcare biobanks.

Stanford laboratory aligns with Pepper Bio to target tough cancers

03-Mar-2022 By Jenni Spinner

The drug discovery firm will work with the Dean Felsher Laboratory, using the company’s transomics platform to discover therapies for untreatable cancers.

People on the Move: March 2022

03-Mar-2022 By Jenni Spinner

This month’s announcements include hiring, expansion, and acquisition news from companies like DFE Pharma, ClinOne, Novartis, LEGO, Benchling, and more.

rare disease day

Rare diseases, very special patients highlighted in event

28-Feb-2022 By Jenni Spinner

The recent Outsourcing-Pharma webinar hosted a trio of industry experts highlighting challenges, opportunities, and innovations in the rare disease realm.

rare disease day 2022

Rare disease research center to use Trialbee recruitment tech

28-Feb-2022 By Jenni Spinner

Ergomed, a global contract research organization, is partnering with Trialbee to improve patient recruitment at its new Rare Disease Innovation Center.

rare disease day 2022

Genomenon forges rare-disease partnership with advocacy group

24-Feb-2022 By Jenni Spinner

The AI-centered genomics company is joining with Don’t Forget Morgan, a group for patients with BPAN, to explore treatments for the neurodegenerative condition.

rare disease day 2022

Lilly planning $700m genetic medicine development center

24-Feb-2022 By Jenni Spinner

The pharmaceutical company’s Lilly Institute for Genetic Medicine reportedly will focus on developing RNA-based therapeutics in a ‘state-of-the-art’ facility.

Emmes contributes data service to pediatric COVID-19 research

21-Feb-2022 By Jenni Spinner

The CRO is helping out on a project exploring the effects of the virus in children; other members of the research team include experts from Duke University.

For rare disease patients, ‘every day is Rare Disease Day’

21-Feb-2022 By Jenni Spinner

On February 23, five days ahead of the day of rare-disease awareness, OSP’s Rare and Orphan Diseases webinar will share insights from top industry experts.

Tech Innovations: February 2022

17-Feb-2022 By Jenni Spinner

This month’s list of announcements about technology, funding, and more includes Medable, Clarify Health, Thermo Fisher Scientific, and other key companies.

Domainex, Parkinson’s UK team up to advance neuroinflammation program

15-Feb-2022 By Nick Taylor

The institute and the research/support organization will collaborate on development of novel therapies aimed at treating the central nervous system disorder.

Clinical research trends include increased emphasis on study design: Advarra

15-Feb-2022 By Jenni Spinner

An expert from the institutional review board services company advises what trends to look for in the clinical trial industry over the course of coming months.

Collaboration to advance development of cancer therapies

14-Feb-2022 By Jenni Spinner

Cullinan Oncology has formed a strategic partnership with the Icahn School of Medicine at Mount Sinai to research and develop targeted therapies for cancer.

Merck restructures to strengthen CDMO business

14-Feb-2022 By Jane Byrne

Darmstadt, Germany headquartered, Merck KGaA, is restructuring its life sciences business.

Online event to address disparities in cancer research, care

08-Feb-2022 By Jenni Spinner

The latest in the Diversity in Oncology series, taking place February 9, will discuss ways academia and community collaboration can narrow representation gaps.

AI can be a powerful tool in drug development, discovery: Tellius

03-Feb-2022 By Jenni Spinner

A leader from the artificial intelligence insights specialist talks discusses how the effective use of advanced analytics can lead to a number of benefits.

WORLD CANCER DAY

Memorial Sloan Kettering announces $100m gift for cancer research

03-Feb-2022 By Jenni Spinner

The oncology center’s Marie-Josée and Henry R. Kravis Cancer Ecosystems Project is intended to elevate the next generation of preclinical cancer research.

People on the Move: February 2022

03-Feb-2022 By Jenni Spinner

This month’s announcements include new hires, promotions, acquisitions, and other events from Saama, Javara, Firma, GlaxoSmithKline, and other companies.

WORLD CANCER DAY

Global campaign aims to increase equity in cancer care

01-Feb-2022 By Jenni Spinner

On World Cancer Day, the Union for International Cancer Control is launching a three-year campaign with the goal to improve cancer care around the globe.

UK research hub launched to tackle rare kidney disease

31-Jan-2022 By Jenni Spinner

The Stoneygate and Kidney Research UK Alport Research Hub aims to accelerate research and develop treatments for Alport syndrome, a rare genetic disorder.